GLK-221 Ophthalmic Solution

· Glaukos Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GLK-221 Ophthalmic Solution, covering 2026-02-10 to 2026-02-10. Get the full timeline:

Most recent: Clinical Trial Update: Placebo-controlled Study to Evaluate the Safety and Efficacy of GLK-221 Ophthalmic Solution in Subjects With Keratoconus [Phase 2]

See pricing